Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intrasubject reliability and validity of somatosensory source localization using a large array biomagnetometer

C C Gallen1, B Schwartz, K Rieke

  • 1Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037.

Electroencephalography and Clinical Neurophysiology
|February 1, 1994
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study.

Gynecologic oncology·2006
Same author

Pooled safety analysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumours: Is rash associated with treatment outcome?

European journal of cancer (Oxford, England : 1990)·2006
Same author

How often should a port-A-cath be flushed?

Cancer investigation·2005
Same author

An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin.

Investigational new drugs·2005
Same author

HTS magnetometers for fetal magnetocardiography.

Neurology & clinical neurophysiology : NCN·2005
Same author

Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2005

This study demonstrates that magnetic source imaging (MSI) reliably pinpoints the somatosensory cortex using neuromagnetic fields. This non-invasive technique offers valid functional localizations valuable for presurgical planning and risk assessment.

Area of Science:

  • Neuroscience
  • Biomagnetism
  • Neuroimaging

Background:

  • Accurate localization of brain activity is crucial for understanding neural function and for presurgical planning.
  • Traditional methods for mapping the somatosensory cortex have limitations in precision and invasiveness.

Purpose of the Study:

  • To assess the reliability and validity of using neuromagnetic fields and magnetic source imaging (MSI) for localizing the human somatosensory cortex.
  • To quantify sources of error in non-invasive neuromagnetic measurements.

Main Methods:

  • Evoked neuromagnetic fields from tactile stimuli using a multi-channel biomagnetometer in 72 repetitive measurements.
  • Analyzed somatosensory evoked responses using an equivalent current dipole model for source localization.
  • Compared magnetic source imaging (MSI) localizations with neuroanatomical landmarks from MRI.

Related Experiment Videos

Main Results:

  • Three major neuromagnetic somatosensory response components consistently localized to the same cortical area.
  • Intrinsic brain activity was identified as the primary source of inter-measurement variability.
  • MSI-derived source localizations were validated against MRI-based estimations of the central sulcus.

Conclusions:

  • Non-invasive biomagnetic localization provides reliable and valid functional mapping of the somatosensory cortex.
  • This technique holds potential for presurgical risk assessment and guiding invasive functional mapping procedures.